Clinical Trials Sponsored by Ocera Therapeutics, Inc.
Total 2980 results
-
Johns Hopkins UniversityNational Multiple Sclerosis Society; Axsome Therapeutics, Inc.Not yet recruitingMultiple Sclerosis | Multiple Sclerosis Fatigue
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.RecruitingLymphoma | Leukemia | Myeloma | Relapsed/Refractory Hematological MalignanciesChina
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
AlaMab Therapeutics (Shanghai) Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
Cellphire Therapeutics, Inc.U.S. Army Medical Research and Development CommandRecruitingCardiac SurgeryUnited States
-
Jeff C. Huffman, MDBioXcel Therapeutics IncWithdrawn
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Y-mAbs TherapeuticsInvicro; Labcorp Corporation of America Holdings, IncWithdrawn
-
Merit E. Cudkowicz, MDDenali Therapeutics Inc.Enrolling by invitation
-
Guru P. SonpavdeQED Therapeutics, Inc.WithdrawnBladder Cancer | Bladder Transitional Cell Carcinoma | Fibroblast Growth Factor Receptor
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Pain TherapeuticsNational Institute on Aging (NIA)Completed
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Ception TherapeuticsCephalonCompletedEosinophilic EsophagitisUnited States, Canada
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Motus Therapeutics, Inc.Michael J. Fox Foundation for Parkinson's ResearchTerminatedParkinson's DiseaseUnited States
-
Ception TherapeuticsCephalonCompletedAsthmaUnited States, Canada
-
Iworks Laser and Vision CenterOcular Therapeutix, Inc.Completed
-
Retina Vitreous Associates of FloridaOcular Therapeutix, Inc.TerminatedDiabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular DegenerationUnited States
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.WithdrawnGraft Vs Host DiseaseUnited States
-
Ophthalmic Consultants of Long IslandOcular Therapeutix, Inc.UnknownPatient PreferenceUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationNot yet recruitingRelapsed or Refractory Follicular Lymphoma
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Belgium, France, Germany, Spain, United Kingdom, Italy
-
Seventh Medical Center of PLA General HospitalGeneCradle Therapeutics, IncRecruiting
-
Edwin Posadas, MDEnviro Therapeutics, Inc.RecruitingCastration-resistant Prostate CancerUnited States
-
Anup KasiCend Therapeutics Inc.RecruitingColon Cancer | Pancreas Cancer | Digestive CancerUnited States
-
Jonsson Comprehensive Cancer CenterMirati Therapeutics Inc.; Phase One FoundationRecruitingRhabdomyosarcomaUnited States
-
Sanjay MohanAbbVie; Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States, Austria, Belgium, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
-
Glenn J. HannaActuate Therapeutics Inc.Active, not recruitingAdenoid Cystic Carcinoma | Metastatic Cancer | Salivary Gland Cancer | Recurrent Salivary Gland CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); SpringWorks Therapeutics, Inc.Active, not recruitingDesmoid Fibromatosis | Recurrent Desmoid Fibromatosis | Unresectable Desmoid FibromatosisUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Merit E. Cudkowicz, MDSeelos Therapeutics, Inc.CompletedAmyotrophic Lateral SclerosisUnited States
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc.Active, not recruiting
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompleted22q11.2 Deletion SyndromeUnited States
-
Craig McDonald, MDCardero Therapeutics, Inc.Completed
-
Pain TherapeuticsNational Institute on Aging (NIA)CompletedAlzheimer Disease | Alzheimer Disease, Early OnsetUnited States
-
Acorda TherapeuticsUnited States Department of Defense; DP Clinical, Inc.TerminatedAcute Spinal Cord Injury
-
VA Office of Research and DevelopmentHelsinn Therapeutics (U.S.), IncTerminated
-
Johns Hopkins UniversityJuvenile Diabetes Research Foundation; iCo Therapeutics Inc.TerminatedDiabetic Macular EdemaUnited States
-
Radboud University Medical CenterDutch Heart Foundation; Synvista Therapeutics, IncCompletedCardiovascular Disease | Physical Activity | Aging | Endothelial DysfunctionNetherlands
-
Mitchel IbachOcular Therapeutix, Inc.Not yet recruiting
-
Clinical Research Center of FloridaOcular Therapeutix, Inc.CompletedBilateral Conjunctivitis (Disorder)United States
-
Nathan SteinleOcular Therapeutix, Inc.UnknownOcular Disease Requiring SurgeryUnited States
-
Rempex (a wholly owned subsidiary of Melinta Therapeutics...Department of Health and Human ServicesRecruitingBacterial InfectionsUnited States
-
University of ColognePfizer; F2G Biotech GmbH; Basilea Pharmaceutica; Cidara Therapeutics Inc.; Matinas...RecruitingInvasive Fungal DiseaseGermany
-
Modulation Therapeutics, Inc.H. Lee Moffitt Cancer Center and Research InstituteRecruitingUveal Melanoma | MetastaticUnited States
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIA; Juno Therapeutics, Inc.Not yet recruiting